Procedures	O
and	O
Outcome	O

The	O
clinical	O
and	O
demographic	O
characteristics	O
of	O
the	O
study	O
participants	O
were	O
obtained	O
before	O
enrolled	O
in	O
the	O
study	O
.	O

All	O
patients	O
were	O
followed	O
-	O
up	O
from	O
day	O
0	O
to	O
day	O
3	O
,	O
improvement	O
,	O
hospital	O
discharge	O
,	O
or	O
death	O
,	O
and	O
one	O
week	O
after	O
hospital	O
discharge	O
,	O
which	O
was	O
scheduled	O
at	O
three	O
or	O
four	O
consecutive	O
visit	O
points	O
.	O

Clinical	O
signs	O
of	O
the	O
patients	O
including	O
heart	B-UnclearOutcome
rate	I-UnclearOutcome
,	O
body	B-UnclearOutcome
temperature	I-UnclearOutcome
,	O
blood	B-UnclearOutcome
pressure	I-UnclearOutcome
,	O
oxygen	B-UnclearOutcome
saturation	I-UnclearOutcome
(	I-UnclearOutcome
SO2	I-UnclearOutcome
)	I-UnclearOutcome
,	O
and	O
,	O
dyspnea	B-UnclearOutcome
,	O
cough	B-UnclearOutcome
,	O
gastrointestinal	B-UnclearOutcome
involvement	I-UnclearOutcome
(	I-UnclearOutcome
GI	I-UnclearOutcome
)	I-UnclearOutcome
symptoms	I-UnclearOutcome
,	O
myalgia	B-UnclearOutcome
,	O
chest	B-UnclearOutcome
pain	I-UnclearOutcome
,	O
and	O
BORG	B-UnclearOutcome
score	I-UnclearOutcome
were	O
assessed	O
before	O
and	O
after	O
treatment	O
(	O
by	O
3	O
days	O
of	O
treatment	O
and	O
discharge	O
time	O
)	O
.	O

The	O
need	B-UnclearOutcome
on	I-UnclearOutcome
oxygen	I-UnclearOutcome
therapy	I-UnclearOutcome
(	I-UnclearOutcome
nasal	I-UnclearOutcome
cannula	I-UnclearOutcome
,	I-UnclearOutcome
mask	I-UnclearOutcome
oxygen	I-UnclearOutcome
,	I-UnclearOutcome
reserve	I-UnclearOutcome
mask	I-UnclearOutcome
,	I-UnclearOutcome
noninvasive	I-UnclearOutcome
ventilation	I-UnclearOutcome
(	I-UnclearOutcome
NIV	I-UnclearOutcome
)	I-UnclearOutcome
,	I-UnclearOutcome
and	I-UnclearOutcome
invasive	I-UnclearOutcome
ventilation	I-UnclearOutcome
)	O
was	O
recorded	O
before	O
and	O
after	O
treatment	O
(	O
by	O
3	O
days	O
of	O
treatment	O
and	O
discharge	O
time	O
)	O
.	O

CT	B-UnclearOutcome
scan	I-UnclearOutcome
findings	I-UnclearOutcome
were	O
also	O
assessed	O
before	O
and	O
one	O
week	O
after	O
treatment	O
only	O
in	O
patients	O
agreed	O
to	O
give	O
informed	O
consent	O
.	O

Other	O
clinical	O
outcomes	O
including	O
mortality	B-UnclearOutcome
rate	I-UnclearOutcome
,	O
the	O
duration	B-UnclearOutcome
of	I-UnclearOutcome
hospitalization	I-UnclearOutcome
in	I-UnclearOutcome
improved	I-UnclearOutcome
patients	I-UnclearOutcome
,	O
and	O
the	O
time	B-UnclearOutcome
(	I-UnclearOutcome
in	I-UnclearOutcome
days	I-UnclearOutcome
)	I-UnclearOutcome
from	I-UnclearOutcome
the	I-UnclearOutcome
initiation	I-UnclearOutcome
of	I-UnclearOutcome
treatment	I-UnclearOutcome
to	I-UnclearOutcome
death	I-UnclearOutcome
were	O
assessed	O
in	O
each	O
group	O
.	O

Laboratory	B-UnclearOutcome
test	I-UnclearOutcome
results	I-UnclearOutcome
including	O
complete	O
blood	B-OutcomeDefinition
count	I-OutcomeDefinition
(	I-OutcomeDefinition
CBC	I-OutcomeDefinition
)	I-OutcomeDefinition
,	I-OutcomeDefinition
C	I-OutcomeDefinition
-	I-OutcomeDefinition
reactive	I-OutcomeDefinition
protein	I-OutcomeDefinition
(	I-OutcomeDefinition
CRP	I-OutcomeDefinition
)	I-OutcomeDefinition
,	I-OutcomeDefinition
erythrocyte	I-OutcomeDefinition
sedimentation	I-OutcomeDefinition
rate	I-OutcomeDefinition
(	I-OutcomeDefinition
ESR	I-OutcomeDefinition
)	I-OutcomeDefinition
,	I-OutcomeDefinition
vein	I-OutcomeDefinition
blood	I-OutcomeDefinition
gas	I-OutcomeDefinition
analysis	I-OutcomeDefinition
(	I-OutcomeDefinition
VBG	I-OutcomeDefinition
)	I-OutcomeDefinition
including	I-OutcomeDefinition
PH	I-OutcomeDefinition
,	I-OutcomeDefinition
Bicarbonate	I-OutcomeDefinition
(	I-OutcomeDefinition
HCO3	I-OutcomeDefinition
)	I-OutcomeDefinition
,	I-OutcomeDefinition
and	I-OutcomeDefinition
partial	I-OutcomeDefinition
pressure	I-OutcomeDefinition
of	I-OutcomeDefinition
carbon	I-OutcomeDefinition
dioxide	I-OutcomeDefinition
(	I-OutcomeDefinition
PCO2	I-OutcomeDefinition
)	I-OutcomeDefinition
,	I-OutcomeDefinition
IL	I-OutcomeDefinition
-	I-OutcomeDefinition
6	I-OutcomeDefinition
,	I-OutcomeDefinition
Ferritin	I-OutcomeDefinition
,	I-OutcomeDefinition
Troponin	I-OutcomeDefinition
,	I-OutcomeDefinition
D	I-OutcomeDefinition
-	I-OutcomeDefinition
dimer	I-OutcomeDefinition
,	I-OutcomeDefinition
lactic	I-OutcomeDefinition
acid	I-OutcomeDefinition
dehydrogenase	I-OutcomeDefinition
(	I-OutcomeDefinition
LDH	I-OutcomeDefinition
)	I-OutcomeDefinition
,	I-OutcomeDefinition
and	I-OutcomeDefinition
creatine	I-OutcomeDefinition
phosphokinase	I-OutcomeDefinition
(	I-OutcomeDefinition
CPK	I-OutcomeDefinition
)	I-OutcomeDefinition
were	O
recorded	O
before	O
and	O
after	O
treatment	O
(	O
by	O
3	O
days	O
of	O
treatment	O
and	O
discharge	O
time	O
)	O
.	O

Clinical	B-UnclearOutcome
signs	I-UnclearOutcome
of	I-UnclearOutcome
the	I-UnclearOutcome
improved	I-UnclearOutcome
patients	I-UnclearOutcome
,	O
including	B-OutcomeDefinition
cough	I-OutcomeDefinition
,	I-OutcomeDefinition
GI	I-OutcomeDefinition
symptoms	I-OutcomeDefinition
,	I-OutcomeDefinition
myalgia	I-OutcomeDefinition
,	I-OutcomeDefinition
chest	I-OutcomeDefinition
pain	I-OutcomeDefinition
,	I-OutcomeDefinition
and	I-OutcomeDefinition
BORG	I-OutcomeDefinition
score	I-OutcomeDefinition
,	O
were	O
assessed	O
one	O
-	O
week	O
after	O
discharge	O
time	O
.	O

All	O
data	O
were	O
considered	O
during	O
the	O
study	O
and	O
follow	O
-	O
up	O
time	O
and	O
recorded	O
on	O
case	O
report	O
forms	O
(	O
CRFs	O
)	O
and	O
the	O
Excel	O
database	O
.	O

The	O
primary	O
endpoint	O
was	O
the	O
time	B-PrimaryOutcome
of	I-PrimaryOutcome
clinical	I-PrimaryOutcome
improvement	I-PrimaryOutcome
and	I-PrimaryOutcome
discharge	I-PrimaryOutcome
from	I-PrimaryOutcome
the	I-PrimaryOutcome
hospital	I-PrimaryOutcome
or	I-PrimaryOutcome
death	I-PrimaryOutcome
whichever	I-PrimaryOutcome
came	I-PrimaryOutcome
first	I-PrimaryOutcome
.	O

Hospital	B-OutcomeDefinition
discharge	I-OutcomeDefinition
was	I-OutcomeDefinition
determined	I-OutcomeDefinition
according	I-OutcomeDefinition
to	I-OutcomeDefinition
the	I-OutcomeDefinition
patients	I-OutcomeDefinition
clinical	I-OutcomeDefinition
and	I-OutcomeDefinition
laboratory	I-OutcomeDefinition
findings	I-OutcomeDefinition
.	I-OutcomeDefinition
Improvement	I-OutcomeDefinition
was	I-OutcomeDefinition
defined	I-OutcomeDefinition
as	I-OutcomeDefinition
BORG	I-OutcomeDefinition
score	I-OutcomeDefinition
>	I-OutcomeDefinition
3	I-OutcomeDefinition
,	I-OutcomeDefinition
improved	I-OutcomeDefinition
dyspnea	I-OutcomeDefinition
,	I-OutcomeDefinition
stopped	I-OutcomeDefinition
fever	I-OutcomeDefinition
for	I-OutcomeDefinition
72	I-OutcomeDefinition
hours	I-OutcomeDefinition
,	I-OutcomeDefinition
SO2	I-OutcomeDefinition
>	I-OutcomeDefinition
93	I-OutcomeDefinition
%	I-OutcomeDefinition
,	I-OutcomeDefinition
tolerated	I-OutcomeDefinition
oral	I-OutcomeDefinition
regimen	I-OutcomeDefinition
(	I-OutcomeDefinition
PO	I-OutcomeDefinition
)	I-OutcomeDefinition
,	I-OutcomeDefinition
normal	I-OutcomeDefinition
urinary	I-OutcomeDefinition
output	I-OutcomeDefinition
and	I-OutcomeDefinition
reduced	I-OutcomeDefinition
CRP	I-OutcomeDefinition
level	I-OutcomeDefinition
without	I-OutcomeDefinition
any	I-OutcomeDefinition
treatment	I-OutcomeDefinition
side	I-OutcomeDefinition
effects	I-OutcomeDefinition
.	O

